Orlance

Orlance, Inc., a Seattle-based biotechnology company developing next-generation DNA and RNA vaccines and therapies, aims to deliver powdered, needle-free, storage-stable nucleic acid vaccines (DNA and/or RNA) through its epidermal vaccine delivery platform.